Home / Author Archives: Market Watch (page 4)

Author Archives: Market Watch

NIH launches 3 new clinical trials studying COVID-19 treatments

The National Institutes of Health this week announced several new clinical trials studying different types of COVID-19 treatments.One new Phase 3 clinical trial will evaluate NeuroRx Inc.’s experimental formulation of aviptadil acetate and Gilead Sciences Inc.’ Veklury in hospitalized COVID-19 ...

Read More »

FDA approves GSK’s endometrial cancer therapy

U.S.-listed shares of GlaxoSmithKline were down 1.4% in trading on Thursday after the Food and Drug Administration said it had granted accelerated approval to the company’s endometrial cancer treatment. The immunotherapy, which was called dostarlimab and is now named Jemperli, ...

Read More »

Square announces new inventory features for its sellers

Square Inc. announced Thursday that it plans to make new inventory-management features available to its sellers. The company is rolling out tools that help sellers automate their inventory-management processes by using barcode scanners to take stock of inventory and receiving ...

Read More »